| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 121868 | Null | 0.0018088833864761 | 0.54192267 |
| NSC 165572 | Pyrido[3,2-g]quinoline-2,5,8,10(1H,9H)-tetrone, 1,4,6-trimethyl- | 0.0018088833864761 | 0.26769416 |
| NSC 704408 | Null | 0.0018088833864761 | -0.25802317 |
| NSC 707094 | Null | 0.0018088833864761 | 0.34836117 |
| NSC 718579 | Null | 0.00180888338647612 | 0.36577439 |
| NSC 709588 | Null | 0.00181371860170654 | -0.38469461 |
| NSC 13479 | Null | 0.00206000157707803 | 0.48255736 |
| NSC 174121 | Methotrexate Derivative | 0.00206000157707803 | 0.17860186 |
| NSC 647638 | 1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) | 0.00206000157707803 | -0.028497901 |
| NSC 666783 | Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol | 0.00206000157707803 | 0.15978266 |